Ono Pharmaceutical

Ono pays $280M upfront for Ionis' antisense oligonucleotide for rare blood cancer
Fierce Biotech
Wed, 03/12/25 - 11:08 am
Ono Pharmaceutical
Ionis Pharmaceuticals
antisense
sapablursen
polycythemia vera
FDA approves Ono's rare tumor drug from $2.4B Deciphera buyout
Fierce Pharma
Sun, 02/16/25 - 07:33 pm
Ono Pharmaceutical
FDA
vimseltinib
tenosynovial giant cell tumors
Japan's Ono Pharma taps Texas startup Shattuck for $227M bifunctional fusion protein deal
Fierce Biotech
Wed, 02/14/24 - 11:33 am
Ono Pharmaceutical
Shattuck Labs
fusion proteins
biobucks
autoimmune diseases
AstraZeneca faces $278M Imfinzi patent infringement lawsuit from co-developer Ono
Fierce Pharma
Tue, 03/1/22 - 10:32 am
AstraZeneca
Ono Pharmaceutical
lung cancer
patents
Imfinzi
Corporate and regulatory developments over the Christmas period
EP Vantage
Thu, 01/2/20 - 11:39 pm
Astellas
M&A
Qiagen
AstraZeneca
Bausch Health
BeiGene
Celyad
Immunomedics
Merck
Merck KGaA
Ono Pharmaceutical
Pfizer
Pharming
Xyphos Biosciences
Bristol-Myers, Ono, Bayer Team Up for Colorectal Cancer Study
Yahoo/Zacks.com
Sat, 07/20/19 - 08:25 pm
Bristol-Myers Squibb
Bayer
Ono Pharmaceutical
Opdivo
Stivarga
metastatic colorectal cancer
Bayer, Bristol-Myers Squibb and Ono Pharma Team on Colorectal Cancer
BioSpace
Thu, 07/18/19 - 10:24 am
Bayer
Bristol-Myers Squibb
Ono Pharmaceutical
metastatic colorectal cancer
Nobel laureate behind Bristol's I-O superstar Opdivo demands a bigger cut
Fierce Pharma
Thu, 04/11/19 - 12:27 pm
Opdivo
Bristol-Myers Squibb
Ono Pharmaceutical
R&D
Opdivo meets OS endpoint in esophageal cancer trial
BioCentury
Wed, 01/9/19 - 07:24 pm
Ono Pharmaceutical
Opdivo
esophageal cancer
Bristol-Myers Squibb
Bristol-Myers teams up with Opdivo maker Ono Pharmaceutical on new I/O programs
Endpoints
Thu, 12/14/17 - 11:16 am
Bristol-Myers Squibb
Opdivo
Ono Pharmaceutical
ONO-4578
immuno-oncology
drug development
Merck to pony up $625M plus Keytruda royalties to settle BMS, Ono patent fight
Fierce Pharma
Mon, 01/23/17 - 11:11 am
Merck
Keytruda
Bristol-Myers Squibb
Ono Pharmaceutical
Opdivo
patents
This $150,000 Cancer Treatment Saved a Pharma Company
Bloomberg
Fri, 03/4/16 - 02:12 pm
Ono Pharmaceutical
Opdivo
Bristol-Myers Squibb
Japan
Merck and Novo join an open-source R&D club with Amgen, Sanofi and Ono
Fierce Biotech
Tue, 02/10/15 - 10:40 am
R&D
Merck
Novo Nordisk
Amgen
Sanofi
Ono Pharmaceutical
Bristol-Myers Has The Future Of Oncology Therapies
Seeking Alpha
Sun, 05/5/13 - 11:00 am
Bristol-Myers Squibb
nivolumab
BMS-936558
non-small cell lung cancer
renal cell carcinoma
melanoma
Ono Pharmaceutical
tivozanib
Aveo Pharmaceuticals
elotuzumab
Merck KGaA, Ono Pharma Collaborate
Yahoo/Zacks
Sat, 10/15/11 - 11:34 am
Merck KGaA
Ono Pharmaceutical
ONO-4641
multiple sclerosis
Stimuvax
non-small cell lung cancer
Bristol-Myers Squibb Zeroes In On A Blockbuster Cancer Drug
Seeking Alpha
Tue, 09/27/11 - 07:31 pm
Bristol-Myers Squibb
Orencia
MDX-1106
BMS-936558
Ono Pharmaceutical